AstraZeneca appeared to play down speculation about the future of its chief executive officer after its shares fell more than 4% on Monday following a U.K. tabloid report that Pascal Soriot was ...

The probe centers around AstraZeneca’s eight or nine employees, Soriot said in a Bloomberg TV interview, noting that the firm employs 12,000 people in the country.

Soriot’s latest remarks came as the CEO trumpeted a “very encouraging” start to 2023. The drugmaker delivered total revenues of around $10.9 billion over the first three months of the year ...

AstraZeneca’sAZN-0.40 % decrease; red down pointing triangle longest-serving chief executive, Pascal Soriot, has no plans to step down for now as the company tries to grab a slice of the booming ...

Pascal Soriot suggested during the 2023 STAT Future Summit that Medicare should start the clock once a drug loses its “orphan” status. ... AstraZeneca CEO Pascal Soriot proposed a new solution.

History is repeating for AstraZeneca CEO Pascal Soriot, who successfully dodged an executive pay revolt at the company’s annual meeting Thursday, echoing a similar situation that played out in 2021.

Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and development center.

AstraZeneca CEO Pascal Soriot who will receive a pay package £18.7 million in 2024 (PA) I s any employee worth paying £18.7m? That’s the monster sum AstraZeneca has awarded its chief executive ...

AstraZeneca boss Sir Pascal Soriot has privately told friends and trusted advisers that he is looking to leave the biggest company in the FTSE 100, The Mail on Sunday understands.

AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why the drugmaker believes it can almost double revenue by 2030. "Biology is complicated, and we're never sure ...

Chinese authorities have detained AstraZeneca employees amid a probe into potential data privacy breaches and unlicensed drug imports. CEO Pascal Soriot assures compliance with Chinese regulations ...